<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="134458">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01873079</url>
  </required_header>
  <id_info>
    <org_study_id>ERCP-PPI ver. 2</org_study_id>
    <nct_id>NCT01873079</nct_id>
  </id_info>
  <brief_title>PPI for Prevention of Post-sphincterotomy Bleeding</brief_title>
  <official_title>Prevention of Delayed Post-sphincterotomy Bleeding by High Dose Proton Pump Inhibitor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The University of Hong Kong</source>
  <oversight_info>
    <authority>Hong Kong: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endoscopic biliary sphincterotomy is a common and important procedure for biliary access and
      therapy during endoscopic retrograde cholangiopancreatography (ERCP). Bleeding is one of the
      important complications related to sphincterotomy. This study determines the role of proton
      pump inhibitor (PPI) in preventing post-sphincterotomy bleeding in patients undergoing ERCP
      and sphincterotomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible patients will be randomized to receive either high dose PPI or standard care. PPI
      will be given before ERCP and continue for one week after the sphincterotomy.

      Both overt and occult bleeding will be documented up to 10 days after the sphincterotomy.
      Bleeding rates of the two groups will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Proportion of patients with bleeding after sphincterotomy</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who require transfusion, endoscopic hemostasis and other intervention to control bleeding</measure>
    <time_frame>10 days</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Bleeding</condition>
  <condition>ERCP</condition>
  <arm_group>
    <arm_group_label>Esomeprazole</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>esomeprazole 40mg bd for 10 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard care</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No other study drug or placebo will be given</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esomeprazole</intervention_name>
    <arm_group_label>Esomeprazole</arm_group_label>
    <other_name>Nexium</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>No PPI or other study medication given</description>
    <arm_group_label>Standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients undergoing ERCP who will require sphincterotomy

        Exclusion Criteria:

          -  Previous sphincterotomy/papillotomy

          -  Previous Polya gastrectomy

          -  Patients on maintenance PPI

          -  Pregnant and lactating women

          -  Age &lt;18 years

          -  Previous liver transplant

          -  unable to consent for study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wai K Leung, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wai K Leung, MD</last_name>
    <phone>852 2255 3348</phone>
    <email>waikleung@hku.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Tong</last_name>
      <phone>852 2255 1674</phone>
      <email>tongsma@hku.hk</email>
    </contact>
    <investigator>
      <last_name>Wai K Leung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>June 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Hong Kong</investigator_affiliation>
    <investigator_full_name>LEUNG Wai Keung</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>ERCP</keyword>
  <keyword>sphincterotomy</keyword>
  <keyword>proton pump inhibitor</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Proton Pump Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
